Market Place
Sourcing Support
Ajanta Pharma Ltd soars 1.25%, up for fifth straight session
22 Nov 2024 //
BUSINESS STD
Ajanta Pharma Ltd gains for third straight session
19 Nov 2024 //
BUSINESS STD
Ajanta Pharma share price zooms 4% as ex-dividend date looms
05 Nov 2024 //
BUSINESS STD
Ajanta Pharma Ltd spurts 2.75%, rises for third straight session
31 Oct 2024 //
BUSINESS STD
DoP Rejects Review Applications on Metoprolol Pricing
24 Oct 2024 //
PHARMABIZ
Ajanta Pharma posts Q1 FY25 consolidated PAT at Rs. 245.77 Cr
01 Aug 2024 //
INDIANPHARMAPOST
Ajanta Pharma reports 18% growth on net profit in Q1FY25
31 Jul 2024 //
PHARMABIZ
Ajanta Pharma`s Generic Paliperidone Receives Approval in US
26 Jun 2024 //
FDA
Ajanta Pharma posts Q4 FY24 consolidated PAT at Rs. 202.72 Cr
04 May 2024 //
INDINPHARMAPOST
Ajanta Pharma`s Generic Varenicline Tartrate Receives Approval in the U.S
19 Mar 2024 //
FDA
Ajanta Pharma`s Generic Oxcarbazepine Receives Approval in the U.S.
23 Feb 2024 //
FDA
Ajanta Pharma posts Q2 FY24 consolidated PAT at Rs. 195.30 Cr
01 Nov 2023 //
INDIAN PHARMA POST
Ajanta Pharma`s Generic Topiramate Receives Approval in the U.S.
15 Aug 2023 //
FDA
Ajanta Pharma looks to expand ops in high-growth Asian, African geographies
02 Jul 2023 //
ECONOMIC TIMES
Ajanta Pharma gets US FDA observations after inspection at Dahej facility
26 Jun 2023 //
LIVEMINT
Ajanta`s Generic Pantoprazole Sodium Receives Approval in the U.S.
09 Feb 2023 //
FDA
Ajanta`s Generic Brexpiprazole Receives Approval in the U.S.
03 Feb 2023 //
FDA
Ajanta`s Generic Fluphenazine Hydrochloride Receives Approval in the U.S.
05 Jan 2023 //
FDA
Ajanta Pharma bags India’s "Best Managed Companies" award
17 Oct 2022 //
INDIANPHARMAPOST
Ajanta Pharma GenericTopiramate Receives Approval in the U.S.
09 Jun 2022 //
FDA
Ajanta Pharma Q2 net profit stood at Rs. 196 crore
30 Oct 2021 //
PHARMABIZ
Ajanta Pharma Ltd`s Generic Tofacitinib Citrate Receives Approval In US
01 Jun 2021 //
FDA
Ajanta Pharma earmarks Rs 250 crore capex for current fiscal
07 May 2021 //
ECONOMICTIMES
Ajanta Pharma`s Generic Sitagliptin Phosphate Receives Approval In US
09 Jan 2021 //
FDA
Ajanta Pharma Ltd`s Generic Tetrabenazine Receives Approval In US
10 Dec 2020 //
FDA
Ajanta Pharma Ltd`s Generic Tofacitinib Receives Tentative Approval In US
15 Sep 2020 //
FDA
Ajanta Pharma`s Generic Doxycycline Hyclate Receive Approval in US
04 Jun 2020 //
FDA
Ajanta Pharma`s Generic Cholestyramine Receive Approval in US
09 Apr 2020 //
FDA
Cadila Healthcare share price hits 52-week high on USFDA nod for cancer drug
08 Apr 2020 //
MONEYCONTROL
Ipca Lab, Ajanta Pharma: Two pharma stocks HDFC Securities is bullish on
03 Mar 2020 //
BUSINESS-STANDARD
Ajanta Pharma`s Generic Valganciclovir Hydrochloride Receive Approval in U.S
14 Jan 2020 //
FDA
Allergan settles Bystolic patent dispute with Ajanta
04 Jan 2020 //
SEEKINGAPLHA
Ajanta Pharma Generic Asenapine Receives Approval in US
17 Dec 2019 //
FDA
Strides Shasun, Ajanta Pharma pass USFDA`s ranitidine impurity test
06 Nov 2019 //
MONEYCONTROL
After US FDA flags ranitidine, DCGI asks state regulators to get antacid tested
25 Sep 2019 //
LIVEMINT
Ajanta Pharma`s Generic Dapagliflozin Receives Tentative Approval in US
14 Sep 2019 //
FDA
Ajanta Pharma`s Generic Ranolazine Receives Approval in US
31 May 2019 //
FDA
Hold Ajanta Pharmaceuticals; target of Rs 1060: ICICI Direct
03 May 2019 //
MONEYCONTROL
Ajanta Pharma`s Generic Clarithromycin Receives Approval in US
01 May 2019 //
FDA
Ajanta Pharma`s Generic Oxybutynin Chloride Receives Approval in US
01 Mar 2019 //
FDA
Ajanta Pharma`s Generic Tadalafil Receives Approval in US
05 Feb 2019 //
FDA
Ajanta Pharma`s Generic Silodosin Receives Approval in US
04 Dec 2018 //
FDA
Ajanta Pharma`s Generic Sildenafil Citrate Receives Approval in US
16 Oct 2018 //
FDA
Ajanta Pharma`s Generic Ranitidine Hydrochloride Receives Approval in US
01 Oct 2018 //
FDA
Ajanta Pharma`s Generic Doxycycline Hyclate Receives Approval in US
28 Sep 2018 //
FDA
Ajanta Pharma`s Generic Silodosin Receives Tentative Approval in US
18 Sep 2018 //
FDA
Ajanta Pharma`s Generic Fenofibrate Receives Approval in US
12 Sep 2018 //
FDA
Ajanta Pharma Q1 net up 12 pc at Rs 106 cr
31 Jul 2018 //
ECONOMIC TIMES
USFDA inspects Dahej facility, no observations issued: Ajanta Pharma
29 Jul 2018 //
ECONOMIC TIMES
Ajanta Pharma Ltd’s Generic Fenofibrate Receives Approval In The US
25 Jul 2018 //
FDA
Ajanta Pharma’s Generic Tadalafil Receives Tentative Approval In US
26 May 2018 //
FDA
Ajanta Pharma’s Generic Sildenafil Citrate Receives Approval In US
08 May 2018 //
FDA
Viagra® (Sildenafil Citrate): Pfizer v. Ajanta Pharma
01 Feb 2018 //
PATENT LITIGATION
Ajanta Pharma manages small profit growth during Q3
25 Jan 2018 //
PHARMABIZ
